ARCHIVES

Also Bristol-Myers Squibb Under Federal Investigation Over Plavix Deal.

This article is from The Cancer Letter archive.

Vol. 32 No. 29 | July 28, 2006

Download PDF Visit The Full Archive

Related Articles

The Selling Begins: CT Offered Beyond High-Risk Group

November 26, 2010

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

February 17, 2012

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

November 27, 1998

President Obama Signs Spending Bill Giving NCI 2.8 Percent Increase

December 18, 2009

In Brief: Three Patients Evaluated For Gene Therapy; Revised Program Instructions Available

November 30, 1990

NEJM Paper Ignites Debate Over Spiral CT Scans For Lung Cancer.

November 3, 2006